Form 8-K - Current report:
SEC Accession No. 0000882095-23-000019
Filing Date
2023-05-05
Accepted
2023-05-05 11:15:24
Documents
14
Period of Report
2023-05-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20230503.htm   iXBRL 8-K 85344
2 EXHIBIT 10.1 ex1012023employeestockpurc.htm EX-10.1 72809
3 EXHIBIT 10.2 ex1022023internationalempl.htm EX-10.2 75053
  Complete submission text file 0000882095-23-000019.txt   404562

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20230503.xsd EX-101.SCH 1912
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20230503_lab.xml EX-101.LAB 24137
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20230503_pre.xml EX-101.PRE 12519
8 EXTRACTED XBRL INSTANCE DOCUMENT gild-20230503_htm.xml XML 11024
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 23892050
SIC: 2836 Biological Products, (No Diagnostic Substances)